U3 PHARMA AG has a total of 13 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Argentina. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CRC FOR BIOPHARMACEUTICAL RESE, SCIL PROTEINS GMBH and XERION PHARMACEUTICALS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | Argentina | 1 | |
#4 | Canada | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Rothe Mike | 11 |
#2 | Treder Martin | 9 |
#3 | Hartmann Susanne | 8 |
#4 | Radinsky Bob | 8 |
#5 | Freeman Dan | 8 |
#6 | Borges Eric | 6 |
#7 | Zwick-Wallasch Esther | 1 |
#8 | Bange Johannes | 1 |
#9 | Bob Radinsky | 1 |
#10 | Prenzel Norbert | 1 |
Publication | Filing date | Title |
---|---|---|
AR056857A1 | DIRECTED ANTIBODIES TO HER-3 (RECEIVER OF THE HUMAN EPIDERMAL GROWTH FACTOR-3) AND ITS USES | |
WO2006125645A2 | Inhibitors of mmp-15 in cancer treatment |